1XJ: 4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-[(4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-[(trifluoromethyl)sulfonyl]phenyl)sulfonyl]benzamide
1XJ is a Ligand Of Interest in 4QNQ designated by the RCSB
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4QNQ_1XJ_D_301 | 85% | 13% | 0.066 | 0.977 | 1.68 | 2.25 | 11 | 25 | 2 | 0 | 100% | 1 |
| 4QNQ_1XJ_B_301 | 83% | 11% | 0.067 | 0.972 | 1.36 | 2.73 | 10 | 29 | 2 | 0 | 100% | 1 |
| 4QNQ_1XJ_H_301 | 83% | 10% | 0.068 | 0.973 | 1.47 | 2.8 | 11 | 29 | 1 | 0 | 100% | 1 |
| 4QNQ_1XJ_G_301 | 82% | 9% | 0.068 | 0.967 | 1.44 | 3.03 | 7 | 32 | 4 | 0 | 100% | 1 |
| 4QNQ_1XJ_A_301 | 81% | 8% | 0.07 | 0.968 | 1.9 | 2.67 | 15 | 32 | 6 | 0 | 100% | 1 |
| 4QNQ_1XJ_K_301 | 81% | 10% | 0.068 | 0.964 | 1.33 | 2.87 | 10 | 37 | 3 | 0 | 100% | 1 |
| 4QNQ_1XJ_E_301 | 78% | 10% | 0.077 | 0.967 | 1.36 | 2.86 | 8 | 26 | 2 | 0 | 100% | 1 |
| 4QNQ_1XJ_L_301 | 77% | 11% | 0.079 | 0.963 | 1.42 | 2.64 | 10 | 35 | 3 | 0 | 100% | 1 |
| 4QNQ_1XJ_C_301 | 76% | 9% | 0.076 | 0.955 | 1.42 | 2.92 | 9 | 33 | 8 | 0 | 100% | 1 |
| 4QNQ_1XJ_F_301 | 73% | 8% | 0.082 | 0.954 | 1.61 | 2.95 | 12 | 36 | 6 | 0 | 100% | 1 |
| 4QNQ_1XJ_I_301 | 71% | 8% | 0.087 | 0.95 | 1.56 | 2.97 | 14 | 32 | 5 | 0 | 100% | 1 |
| 4QNQ_1XJ_J_301 | 70% | 8% | 0.087 | 0.948 | 1.5 | 3.04 | 11 | 26 | 7 | 0 | 100% | 1 |
| 6QGH_1XJ_A_401 | 83% | 16% | 0.065 | 0.966 | 2.34 | 1.31 | 12 | 8 | 3 | 0 | 100% | 1 |
| 4LVT_1XJ_A_301 | 76% | 34% | 0.081 | 0.965 | 0.92 | 1.63 | 2 | 19 | 2 | 0 | 100% | 1 |














